Paid Clinical Trials District of Columbia

Discover 818 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 818

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Washington, Falls Church, Richmond, Wynnewoodshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Recruiting

PHASE3

Sponsor:

Cytokinetics

Location:

Washington, Falls Church, Baltimore, Charlottesvilleshow 45 more

Code:

NCT06081894

Conditions

Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Aficamten

Placebo

Mucopolysaccharidosis I (MPS I) Registry

Recruiting

Sponsor:

Genzyme, a Sanofi Company

Location:

Washington, Baltimore, Charlottesville, Philadelphiashow 62 more

Code:

NCT00144794

Conditions

Mucopolysaccharidosis I (MPS I)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Natural History of Sickle Cell Disease

Recruiting

Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Location:

Washington, Bethesda

Code:

NCT00081523

Conditions

Pain Crisis

Eligibility Criteria

Sex: All

Age: 2 - 70+

Healthy Volunteers: Not accepted

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Recruiting

PHASE3

Sponsor:

Tenax Therapeutics, Inc.

Location:

Washington, Philadelphia, Pittsburgh, New Yorkshow 31 more

Code:

NCT05983250

Conditions

Pulmonary Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TNX-103

Placebo

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

Recruiting

PHASE3

Sponsor:

University of Pittsburgh

Location:

Washington, Baltimore, Richmond, Pittsburghshow 14 more

Code:

NCT04084080

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Red Blood Cell

Standard of care

Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

Recruiting

PHASE3

Sponsor:

Center for Vulvovaginal Disorders

Location:

Washington, New York

Code:

NCT03782480

Conditions

Menopause

Genitourinary Syndrome of Menopause

Vulvovaginal Atrophy

Menopause Syndrome

Dyspareunia

Eligibility Criteria

Sex: Female

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Intrarosa

Placebos

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

Recruiting

PHASE3

Sponsor:

Hoffmann-La Roche

Location:

Washington, Fairfax, Philadelphia, Newport Newsshow 70 more

Code:

NCT06047080

Conditions

Large B-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Glofitamab

Polatuzumab vedotin

Rituximab

Cyclophosphamide

Doxorubicin

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age with Relapsed/Refractory CBFA2T3::GLIS2 AML

Recruiting

PHASE1

PHASE2

Sponsor:

Sutro Biopharma, Inc.

Location:

Washington, Richmond, Philadelphia, Birmingham

Code:

NCT06679582

Conditions

Acute Myeloid Leukemia (AML)

Eligibility Criteria

Sex: All

Age: 1 - 12

Healthy Volunteers: Not accepted

Interventions

Luveltamab tazevibulin

BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Recruiting

PHASE2

Sponsor:

Georgetown University

Location:

Washington, Hackensack

Code:

NCT05558982

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BXCL701

Pembrolizumab

Popular cities in District of Columbia

Washington, D.C.